Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » Melbourne NET Forum 2024

Melbourne NET Forum 2024

  • November 29, 2024
Watch the forum HERE
On Thursday 28th November 2024, NeuroEndocrine Cancer Australia (NECA) facilitated the Melbourne NET Patient Forum at Peter MacCallum Cancer Centre.
 
We had a great turn out with over 30 patients, family, friends and carers attending the event. The forum went for two hours, and it was a full evening with amazing presenters, questions and discussions.  
 
The agenda included a diverse range of topics including:
  • Professor Michael Michael, Medical Oncologist at Peter MacCallum Cancer Centre gave an overview of NETS, an update on Medical Oncology & Clinical trials.
  • Associate Professor Grace Kong is a Nuclear Medicine Physician at Peter MacCallum Cancer Centre gave an overview of what Peptide Receptor Radionuclide Therapy is, then an update on Nuclear Medicine & Clinical Trials.
  • Associate Professor Cherie Chiang, Endocrinologist & Chemical Pathologist, provided an informative overview on guideline updates of symptoms and risk factors for carcinoid crisis in surgery / procedures and the development of spot urine 5HIAA which included food restrictions & timeframes for the test.
  • Dr Erin Laing is a NET Specialist Dietitian who works at the Peter MacCallum Cancer Centre who gave an insightful overview on nutrition and current research & guidelines available.
  • Kate Wakelin, NET Clinical Nurse Consultant at Peter MacCallum Cancer Centre provided an overview on the NET Nurse Clinic at Peter Mac.
  • Meredith Cummins, CEO of NECA, then provided an insightful update on NECA and facilitated Q & A time, which included some great discussions.
Thank you to everyone who attended the Melbourne NET Patient Forum and a big thank you to our guest speakers.
 

Click here to view the Forum.

IMG_0559
IMG_0547
IMG_0541
IMG_0536
Melbourne Forum
PXL_20241128_092400473.MP~2

Share this post

Recent posts

Rare Cancers Roundtable

September 26, 2025

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

September 26, 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

September 20, 2025

Will Norman Nurse Webinar on Neuroendocrine Cancer

September 19, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousBridging funding to enable faster access to medicines in Australia
NextBelzutifan listed on PBS 1st December 2024Next

Related Posts

Rare Cancers Roundtable

NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

Each year on 10 November for World Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia joins the global movement to raise awareness of Neuroendocrine Tumours (NETs). This

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

NECA CEO Meredith Cummins attended Shane Kent’s post Arch2Arc event on Friday 19 September 2025 in Brisbane. It was such a great night where Shane’s family, friends

Will Norman Nurse Webinar on Neuroendocrine Cancer

On 17 September, NeuroEndocrine Cancer Australia, NeuroEndocrine UK, and NeuroEndocrine New Zealand came together to deliver the Will Norman Nurse Webinar on Neuroendocrine Cancer. Hosted

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin